Published in
Springer (part of Springer Nature), Breast Cancer Research and Treatment, 3(105), p. 237-246
DOI: 10.1007/s10549-006-9450-2
Links
Tools
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells
Journal article published in 2006 by
Juan A. Marchal 
,
María C. Núñez,
Inés Suárez,
Mónica Díaz-Gavilán,
José A. Gómez-Vidal,
Houria Boulaiz,
Fernando Rodríguez-Serrano,
Miguel A. Gallo,
Antonio Espinosa,
Antonia Aránega,
Joaquín M. Campos
,
María C. Núñez,
Inés Suárez,
Mónica Díaz-Gavilán,
José A. Gómez-Vidal,
Houria Boulaiz,
Fernando Rodríguez-Serrano,
Miguel A. Gallo,
Antonio Espinosa,
Antonia Aránega,
Joaquín M. Campos
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 